Metabolic syndrome and cancer risk

European Journal of Cancer

Volumn 44, Issue 2, 2008, Pages 293-297

  Russo, Antonio ^a   Autelitano, Mariangela ^a   Bisanti, Luigi ^a  

^a Local Health Authority of Milan   (Italy)

Author keywords

Cancer registry; Cohort study; Epidemiologic method; Epidemiology; Metabolic syndrome; Neoplasm; Prospective studies

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT;

ADULT; ARTICLE; BILE DUCT CANCER; BILIARY TRACT CANCER; BLADDER CANCER; BRAIN CANCER; BREAST CANCER; BRONCHUS CANCER; CANCER MORTALITY; CANCER REGISTRY; CANCER RISK; COLON CANCER; COLORECTAL CANCER; CONFIDENCE INTERVAL; DIGESTIVE SYSTEM CANCER; ENDOMETRIUM CANCER; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; GALLBLADDER CANCER; HODGKIN DISEASE; HUMAN; ITALY; KIDNEY CANCER; LARYNX CANCER; LEUKEMIA; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; MELANOMA; METABOLIC SYNDROME X; MULTIPLE MYELOMA; NERVOUS SYSTEM TUMOR; NONHODGKIN LYMPHOMA; PANCREAS CANCER; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; RISK ASSESSMENT; SALIVARY GLAND CANCER; SEX DIFFERENCE; STOMACH CANCER; THYROID CANCER; URINARY TRACT CANCER; UTERINE CERVIX CANCER; UTERUS CANCER;

ADULT; AGED; FEMALE; HUMANS; INCIDENCE; ITALY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NEOPLASMS; RISK FACTORS;

EID: 38149021424     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2007.11.005     Document Type: Article

References (27)

1. Grundy S.M., Brewer B.H., Cleeman J.I., Smith S.C., and Lenfant C. Definition of metabolic syndrome. Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation 109 (2004) 433-438
2. Eckel R.H., Grundy S.M., and Zimmet P.Z. The metabolic syndrome. Lancet 365 (2005) 1415-1428
3. Opie L.H. Metabolic syndrome. Circulation 115 (2007) 32-35
4. Hamet P. Cancer and hypertension. An unresolved issue. Hypertension 28 (1996) 321-324
5. Soler M., Chatenoud L., Negri E., Parazzini F., Franceschi S., and La Vecchia C. Hypertension and hormone-related neoplasms in women. Hypertension 34 (1999) 320-325
6. Mason P.R. Calcium channel blockers, apoptosis and cancer: is there a biologic relationship?. J Am Coll Cardiol 34 (1999) 1857-1866
7. Wideroff L., Gridley G., Mellemkjaer L., et al. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 89 (1977) 1360-1365
8. El-Serag H., Richardson P.A., and Everhart J.E. The role of diabetes in hepatocellular carcinoma: a case-control study among United States veterans. Am J Gastroenterol 96 (2001) 2462-2467
9. Zendehdel K., Nyrén O., Östenson C., Adami H.O., Ekbom O., and Ye W. Cancer incidence in patients with type 1 diabetes mellitus: A population-based cohort study in Sweden. J Natl Cancer Inst 95 (2003) 1797-1800
10. Davila J.A., Morgan R.O., Shaib Y., McGlynn K.A., and El-Serag H. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut 54 4 (2005) 533-539
11. Wang F., Gupta S., and Holly H.A. Diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay area, California. Cancer Epidemiol Biomarkers Prev 15 (2006) 1458-1463
12. Calle E.E., Rodriguez C., Walker-Thurmond K., and Thun M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348 (2003) 1625-1638
13. Overvad K. Body weight, physical activity and cancer. IARC Sci Publ 156 (2002) 235-236
14. Calle E.E., and Thun M.J. Obesity and cancer. Oncogene 23 (2004) 6365-6378
15. McMillan D.C., Sattar N., and McArdle C.S. ABC of obesity. Obesity and cancer. BMJ 333 (2006) 1109-1111
16. Laukkanen J.A., Laaksonen D.E., Niskanen L., Pukkala E., Hakkarainen A., and Salonen J.T. Metabolic syndrome and the risk of prostate cancer in Finnish men: A population-based study. Cancer Epidemiol Biomarkers Prev 13 (2004) 1646-1650
17. Stürmer T., Buring J.E., Lee I.M., Gaziano J.M., and Robert J.G. Metabolic abnormalities and risk for colorectal cancer in the Physicians' Health Study. Cancer Epidemiol Biomarkers Prev 15 (2006) 2391-2397
18. Tande A.J., Platz E.A., and Folsom A.R. The metabolic syndrome is associated with reduced risk of prostate cancer. Am J Epidemiol 164 (2006) 1094-1102
19. Lund Haheim L., Wisloff T.F., Holme I., and Nafstad P. Metabolic syndrome predicts prostate cancer in a cohort of middle-aged Norwegian men followed for 27 years. Am J Epidemiol 164 (2006) 769-774
20. Ahmed R.L., Schmitz K.H., Anderson K.E., Rosamond W.D., and Folsom A.R. The metabolic syndrome and risk of incident colorectal cancer. Cancer 107 (2006) 28-36
21. Hu G., Qiao Q., Tuomilehto J., Balkau B., Borch-Johnsen K., Pyorala K., and for DECODE Study Group. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 164 (2004) 1066-1076
22. Ford E.S., Giles W.H., and Mokdad A.H. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 27 (2004) 2444-2449
23. Weiderpass E., Persson I., Adami H.O., Magnusson C., Lindgren A., and Baron J.A. Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control 11 (2000) 185-192
24. Anderson K.E., Anderson E., Mink P.J., et al. Diabetes and endometrial cancer in the Iowa women's health study. Cancer Epidemiol Biomarkers Prev 10 (2001) 611-616
25. Friberg E., Mantzoros C.S., and Wolk A. Diabetes and risk of endometrial cancer: A population-based prospective cohort study. Cancer Epidemiol Biomarkers Prev 16 (2007) 276-280
26. Furberg A.S., and Thune I. Metabolic abnormalities (hypertension, hyperglycemia and overweight), lifestyle (high energy intake and physical inactivity) and endometrial cancer risk in a Norwegian cohort. Int J Cancer 104 (2003) 669-676
27. Yu H., and Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 92 (2000) 1472-1489